Futura Medical plc (LSE:FUM) has announced a significant leadership transition following consultations with its largest shareholder. Effective immediately, Jeff Needham and James Barder have stepped down from their roles as Non-Executive Chair and Chief Executive Officer, respectively. Stepping in as Interim CEO is Alex Duggan, a seasoned executive with more than 25 years of experience in the consumer healthcare industry.
Duggan’s appointment signals a new phase for Futura, as he leads the company through a strategic review aimed at unlocking future growth. With a strong background in commercial strategy and product development, he is expected to capitalize on Futura’s proprietary technology and expanding product pipeline to drive value creation.
About Futura Medical plc
Futura Medical is a consumer healthcare company focused on developing and globally marketing innovative, clinically proven products in the sexual health space. The company specializes in topical gel-based formulations, with its flagship product, Eroxon®, targeting unmet needs in the erectile dysfunction (ED) market.
Leave a Reply